Cargando…

Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19

Treatment of the cytokine release syndrome (CRS) has become an important part of rescuing hospitalized COVID-19 patients. Here, we systematically explored the transcriptional regulators of inflammatory cytokines involved in the COVID-19 CRS to identify candidate transcription factors (TFs) for thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santoso, Clarissa S., Li, Zhaorong, Rottenberg, Jaice T., Liu, Xing, Shen, Vivian X., Fuxman Bass, Juan I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215608/ https://www.ncbi.nlm.nih.gov/pubmed/34163359 http://dx.doi.org/10.3389/fphar.2021.673485

Ejemplares similares

In vitro Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19
por: Santoso, Clarissa S., et al.
Publicado: (2020)

Global landscape of mouse and human cytokine transcriptional regulation
por: Carrasco Pro, Sebastian, et al.
Publicado: (2018)

Comprehensive mapping of the human cytokine gene regulatory network
por: Santoso, Clarissa S, et al.
Publicado: (2020)

Paired yeast one-hybrid assays to detect DNA-binding cooperativity and antagonism across transcription factors
por: Berenson, Anna, et al.
Publicado: (2023)

Discovering human transcription factor physical interactions with genetic variants, novel DNA motifs, and repetitive elements using enhanced yeast one-hybrid assays
por: Shrestha, Shaleen, et al.
Publicado: (2019)

Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and Management
por: Hu, Tao
Publicado: (2022)

The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?
por: Charli, Jean-Louis, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor-Related Cytokine Release Syndrome: Analysis of WHO Global Pharmacovigilance Database
por: Ceschi, Alessandro, et al.
Publicado: (2020)

Human Virus Transcriptional Regulators
por: Liu, Xing, et al.
Publicado: (2020)

Targeting Mechano-Transcription Process as Therapeutic Intervention in Gastrointestinal Disorders
por: Geesala, Ramasatyaveni, et al.
Publicado: (2021)

A Multitarget Therapeutic Peptide Derived From Cytokine Receptors Based on in Silico Analysis Alleviates Cytokine-Stimulated Inflammation
por: Chang, Chun-Chun, et al.
Publicado: (2022)

The therapeutic effect and mechanism of parthenolide in skeletal disease, cancers, and cytokine storm
por: Zhu, Sipin, et al.
Publicado: (2023)

Targeting Cytokine Release Through the Differential Modulation of Nrf2 and NF-κB Pathways by Electrophilic/Non-Electrophilic Compounds
por: Fagiani, Francesca, et al.
Publicado: (2020)

Targeting Mechanotransduction at the Transcriptional Level: YAP and BRD4 Are Novel Therapeutic Targets for the Reversal of Liver Fibrosis
por: Zhubanchaliyev, Altynbek, et al.
Publicado: (2016)

Immunotherapy targeting cytokines in neuropathic pain
por: Lees, Justin G., et al.
Publicado: (2013)

Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
por: Liu, Yadan, et al.
Publicado: (2021)

Prediction of genome-wide effects of single nucleotide variants on transcription factor binding
por: Carrasco Pro, Sebastian, et al.
Publicado: (2020)

Publisher Correction: Prediction of genome-wide effects of single nucleotide variants on transcription factor binding
por: Carrasco Pro, Sebastian, et al.
Publicado: (2021)

miR-21, Mediator, and Potential Therapeutic Target in the Cardiorenal Syndrome
por: Huang, Cheng-Kai, et al.
Publicado: (2020)

Continuous Renal Replacement Therapy With oXiris Filter May Not be an Effective Resolution to Alleviate Cytokine Release Syndrome in Non-AKI Patients With Severe and Critical COVID-19
por: Kang, Kai, et al.
Publicado: (2022)

Therapeutic Implications of FABP4 in Cancer: An Emerging Target to Tackle Cancer
por: Sun, Naihui, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches
por: Mannino, Federica, et al.
Publicado: (2020)

Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome
por: Rubsamen, Reid, et al.
Publicado: (2020)

Systematic Review of Membrane Components of Gram-Positive Bacteria Responsible as Pyrogens for Inducing Human Monocyte/Macrophage Cytokine Release
por: Rockel, Christoph, et al.
Publicado: (2012)

Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis
por: Ma, Hongbo, et al.
Publicado: (2022)

Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson’s disease
por: He, Ting, et al.
Publicado: (2023)

Prostaglandin Reductase 1 as a Potential Therapeutic Target for Cancer Therapy
por: Wang, Xing, et al.
Publicado: (2021)

Hydrogen Sulfide (H(2)S)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases
por: Zhang, Lei, et al.
Publicado: (2018)

Prednisone-hydrogen sulfide releasing hybrid shows improved therapeutic profile in asthma
por: Cerqua, Ida, et al.
Publicado: (2023)

Cytokine release syndrome
por: Shimabukuro-Vornhagen, Alexander, et al.
Publicado: (2018)

Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy
por: Wang, Xing, et al.
Publicado: (2023)

Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
por: Peter, Angela E., et al.
Publicado: (2021)

Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets
por: Pelaia, Corrado, et al.
Publicado: (2022)

Therapeutics Development for Alagille Syndrome
por: Sanchez, Phillip, et al.
Publicado: (2021)

Novel Therapeutic Target Critical for SARS-CoV-2 Infectivity and Induction of the Cytokine Release Syndrome
por: Harless, William W., et al.
Publicado: (2023)

Targeting Oxidative Stress and Inflammation in Intervertebral Disc Degeneration: Therapeutic Perspectives of Phytochemicals
por: Kang, Liang, et al.
Publicado: (2022)

Folate-Targeted PEGylated Magnetoliposomes for Hyperthermia-Mediated Controlled Release of Doxorubicin
por: Cintra, Emílio R., et al.
Publicado: (2022)

Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18
por: McHugh, Douglas, et al.
Publicado: (2014)

Advancements in lead therapeutic phytochemicals polycystic ovary syndrome: A review
por: Luo, Er-Dan, et al.
Publicado: (2023)

CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome
por: Zheng, Cankun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q2369qc302vo032l333ghtsocd